Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

Lupus has been linked to the Epstein-Barr virus – which causes glandular fever, or mono – before, but we now have evidence of ...

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring ...

Researchers at the University of Bonn have uncovered how a kidney RNA molecule can trigger autoimmune disease. In mice, a ...

From 2014 to 2021, approximately only one-third of US adults diagnosed with hepatitis C received treatment, despite curative therapies.

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Week 48 endpoint analysis from the Company’s Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) demonstrated that participants ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial.

At an international conference, researchers at the forefront of animal-human transplantation compared notes and allowed ...